Latest News

  • Baltimore Firm Raises $110 Million To Bring Johns Hopkins' Cancer-Detecting Blood Test To Market

    The Baltimore Sun | A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test, developed by Johns Hopkins researchers, that doctors would give patients during routine physicals.

    May 31, 2019
  • Forming A New Diagnostics Landscape: An Overview Of The Next Generation Dx Summit

    Diagnostics World News | At the Next Generation Dx Summit, a full program will explore point-of-care diagnostics, immuno-oncology, digital pathology and AI, and all of the accompanying regulatory and reimbursement questions.

    May 31, 2019
  • Washington University, University of North Carolina Team To Evaluate Infant Autism Diagnosis

    Diagnostics World News Brief | A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy. Researchers believe that if they can detect evidence of the disorder earlier, behavioral interventions can begin sooner than currently possible, which may help improve outcomes for affected children.

    May 30, 2019
  • Two Pore Guys Is Rebranding, TTP, And More: News From May 2019

    Diagnostics World News | May featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Two Pore Guys, TTP, Caris, and more.

    May 30, 2019
  • The Challenges Of Conducting Precision Oncology Trials On A Global Scale

    Diagnostics World News | Conducting a trial in various countries requires quite a learning curve, from varying regulatory requirements to the simple language barrier.

    May 29, 2019
  • The Reliability Of Bioassay And Their Impact On The Consumer

    Diagnostics World News | With the reliability of bioassays being a concern, change is inevitable. A certain level of re-education is required, both for the primary care doctors and the patients themselves.

    May 28, 2019
  • How Researchers Are Testing The Validity Of Variant Testing

    Diagnostics World News | The validity of variant calling and discordant data has recently been called into question. Kanwal Raghav is on a mission to address this issue, designing clinical trials that can assess patient outcome based on the various cell-free DNA assays available.

    May 24, 2019
  • How Point-Of-Care Can Bridge The Gap Between Engineering And Medicine

    Diagnostics World | Collaborating with engineers and clinicians at various universities and institutions allows Ping Wang, Chief of Clinical Chemistry and Director of the Core Laboratory Hospital of the University of Pennsylvania, to see the emerging trends in clinical care. One such trend is at the point-of-care, which Wang believes should serve as a bridge between the engineering world and the medicine world.

    May 22, 2019
  • Barriers To Entry: The Patent System's Silver Bullet For Medical Companies

    Diagnostics World News Contributed Commentary | There are many barriers to commercial entry for medical technologies, including FDA approval, significant and long-term capital investment, slow market adoption, large established competitors, and market penetration hurdles resulting from group purchasing organizations (GPOs). US patents can, and often are, the lifeline to emerging medical technologies.

    May 17, 2019
  • Turning Primary Care EHRs Into Public Health Assets

    Diagnostics World News | AllianceChicago is one of the oldest Health Center Controlled Networks supporting HRSA-funded health centers, making it unique in terms of size and mission. A key objective is to turn their electronic health records (EHRs) into public health assets.

    May 14, 2019